Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T19:12:45.028Z.
Calculation as of: 2026-10-06T19:12:45.028Z.
Quote observation: 2026-10-06T19:10:11.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2ce25f957fe83095360266a8eba44a0c9f304ca71e6017df3a9cc6b1c586d311
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
MapLight Therapeutics, Inc.
Market Cap
$411.32M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$412.32M
Operating Cash Flow Yield
N/A
TTM Avg
2.44%
3Y Avg
2.44%
5Y Avg
2.42%
Market Cap
$413.62M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$418.57M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$401.88M
Operating Cash Flow Yield
1.92%
TTM Avg
1.03%
3Y Avg
1.03%
5Y Avg
0.91%
Market Cap
$401.70M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MapLight Therapeutics, Inc. (MPLT) | $411.32M | N/A | N/A | N/A | N/A |
| Strata Critical Medical, Inc. (SRTA)vs › | $412.32M | N/A | 2.44% | 2.44% | 2.42% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $413.62M | N/A | N/A | N/A | N/A |
| Neurogene Inc. (NGNE)vs › | $407.07M | N/A | N/A | N/A | N/A |
| Rezolute, Inc. (RZLT)vs › | $405.39M | N/A | N/A | N/A | N/A |
| Senseonics Holdings, Inc. (SENS)vs › | $418.57M | N/A | N/A | N/A | N/A |
| Carlsmed, Inc. (CARL)vs › | $405.87M | N/A | N/A | N/A | N/A |
| Myriad Genetics, Inc. (MYGN)vs › | $401.88M | 1.92% | 1.03% | 1.03% | 0.91% |
| Shoulder Innovations, Inc. (SI)vs › | $401.70M | N/A | N/A | N/A | N/A |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $401.74M | N/A | 24.51% | 24.51% | 24.51% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
